EtDO-P4 is a nanomolar inhibitor of glycosphingolipid (GSL) synthesis. EtDO-P4 suppresses activation of the EGFR-induced cancer, including Burkitt's lymphoma[1].
[1]. Seung-Yeol Park, et al. Globoside promotes activation of ERK by interaction with the epidermal growth factor receptor. Biochim Biops Acta. 2012 Jul;1820(7):1141-8.
















